Noronex Statistics

Total Valuation

Noronex has a market cap or net worth of AUD 8.91 million. The enterprise value is 8.45 million.

Market Cap	8.91M
Enterprise Value	8.45M

Important Dates

The next estimated earnings date is Thursday, June 12, 2025.

Earnings Date	Jun 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Noronex has 557.12 million shares outstanding. The number of shares has increased by 50.74% in one year.

Current Share Class	n/a
Shares Outstanding	557.12M
Shares Change (YoY)	+50.74%
Shares Change (QoQ)	+19.11%
Owned by Insiders (%)	11.93%
Owned by Institutions (%)	12.45%
Float	362.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.48
PB Ratio	10.32
P/TBV Ratio	10.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.56
EV / Sales	36.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.23

Financial Position

The company has a current ratio of 1.22

Current Ratio	1.22
Quick Ratio	0.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -170.88% and return on invested capital (ROIC) is -107.16%.

Return on Equity (ROE)	-170.88%
Return on Assets (ROA)	-81.94%
Return on Invested Capital (ROIC)	-107.16%
Return on Capital Employed (ROCE)	-384.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.08% in the last 52 weeks. The beta is 3.00, so Noronex's price volatility has been higher than the market average.

Beta (5Y)	3.00
52-Week Price Change	+23.08%
50-Day Moving Average	0.02
200-Day Moving Average	0.01
Relative Strength Index (RSI)	46.25
Average Volume (20 Days)	1,171,579

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Noronex had revenue of AUD 231,643 and -3.30 million in losses. Loss per share was -0.01.

Revenue	231,643
Gross Profit	231,643
Operating Income	-3.32M
Pretax Income	-3.31M
Net Income	-3.30M
EBITDA	n/a
EBIT	-3.32M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 500,752 in cash and n/a in debt, giving a net cash position of 500,752 or 0.00 per share.

Cash & Cash Equivalents	500,752
Total Debt	n/a
Net Cash	500,752
Net Cash Per Share	0.00
Equity (Book Value)	863,696
Book Value Per Share	0.00
Working Capital	173,929

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.48 million and capital expenditures -132,859, giving a free cash flow of -2.62 million.

Operating Cash Flow	-2.48M
Capital Expenditures	-132,859
Free Cash Flow	-2.62M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,432.09%
Pretax Margin	-1,427.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Noronex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.74%
Shareholder Yield	-50.74%
Earnings Yield	-37.01%
FCF Yield	-29.36%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Noronex has an Altman Z-Score of -18.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.38
Piotroski F-Score	n/a